A detailed history of Atlas Capital Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 8,192 shares of NVO stock, worth $1.14 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
8,192
Previous 9,192 10.88%
Holding current value
$1.14 Million
Previous $951 Million 10.62%
% of portfolio
0.16%
Previous 0.14%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$102.11 - $135.92 $102,110 - $135,920
-1,000 Reduced 10.88%
8,192 $1.05 Billion
Q4 2023

Feb 15, 2024

BUY
$87.78 - $105.45 $77,509 - $93,112
883 Added 10.63%
9,192 $951 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $368,670 - $808,935
4,054 Added 95.28%
8,309 $756 Million
Q1 2023

May 16, 2023

SELL
$132.34 - $159.14 $4,499 - $5,410
-34 Reduced 0.79%
4,255 $677 Million
Q4 2022

Feb 15, 2023

SELL
$102.55 - $135.33 $232,173 - $306,387
-2,264 Reduced 34.55%
4,289 $580 Million
Q3 2022

Nov 08, 2022

SELL
$95.28 - $116.93 $47,258 - $57,997
-496 Reduced 7.04%
6,553 $653 Million
Q2 2022

Aug 16, 2022

SELL
$103.24 - $121.81 $74,952 - $88,434
-726 Reduced 9.34%
7,049 $785 Million
Q1 2022

May 11, 2022

BUY
$93.1 - $112.54 $17,782 - $21,495
191 Added 2.52%
7,775 $863 Million
Q4 2021

Feb 01, 2022

BUY
$95.88 - $117.08 $218,222 - $266,474
2,276 Added 42.88%
7,584 $849 Million
Q3 2021

Oct 28, 2021

BUY
$84.42 - $106.62 $448,101 - $565,938
5,308 New
5,308 $509,000
Q4 2018

Jan 29, 2019

SELL
$41.54 - $47.25 $246,456 - $280,334
-5,933 Closed
0 $0
Q3 2018

Nov 09, 2018

SELL
$46.76 - $51.24 $206,538 - $226,327
-4,417 Reduced 42.68%
5,933 $0
Q2 2018

Jul 30, 2018

SELL
$44.29 - $50.42 $590,917 - $672,703
-13,342 Reduced 56.31%
10,350 $0
Q1 2018

Apr 18, 2018

BUY
$48.49 - $58.14 $1.15 Million - $1.38 Million
23,692 New
23,692 $0

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $313B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.